Form 4: Bio-Rad Laboratories EVP Andrew J. Last Reports Stock Transactions
SEC Form 4 Filing
Andrew J. Last, EVP and Chief Operating Officer of Bio-Rad Laboratories, reports the vesting of restricted stock units and subsequent disposal of shares to cover tax obligations.
Summary
- On September 1, 2024, Andrew J. Last, EVP and Chief Operating Officer of Bio-Rad Laboratories, reported transactions involving Bio-Rad A Common Stock.
- These transactions included the vesting of restricted stock units and the disposal of shares to satisfy tax withholding obligations.
- Specifically, restricted stock units vested on September 1, 2024, relating to grants from September 1, 2020, September 1, 2021, September 1, 2022 and September 1, 2023.
- A total of 3,655 restricted stock units vested.
- Shares were also acquired under the Bio-Rad Employee Stock Purchase Plan on June 30, 2024.
- Following these transactions, Last directly owns 7,559.4501 shares of Bio-Rad A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock transactions. The vesting of stock options is generally a positive sign, but the sale of shares to cover taxes is a normal occurrence.
Positives
- The vesting of restricted stock units indicates that performance milestones have been met.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider activity related to compensation.
Key Dates
| Date | Description |
|---|---|
| 09/02/2020 | Date of grant of 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 09/01/2021 | Date of grant of 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 09/01/2022 | Date of grant of 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 09/01/2023 | Date of grant of 5,008 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 06/30/2024 | Date of acquisition of shares under the Bio-Rad Employee Stock Purchase Plan. |
| 09/01/2024 | Date of vesting of restricted stock units and related transactions. |
| 09/02/2024 | Date of vesting of restricted stock units and related transactions. |
| 09/04/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.